Thumbnail

أمريكا الشمالية علاج سرطان البنكرياس وتشخيص السوق - مقسم حسب نوع السرطان والجغرافيا (2020-2025)

Looking to buy the report?

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Research Methodology                         

2. Executive Summary                                  

3. Market Overview                                       

                3.1 Market Drivers                          

                                3.1.1 Large Number of Unmet Needs in the Disease         

                                3.1.2 Increase in the Healthcare Expenditure   

                                3.1.3 Increasing Concern across the Globe            

                3.2 Market Restraints                    

                                3.2.1 Inadequate Results after Treatment             

                                3.2.2 Difficulties in Early Diagnosis            

                                3.2.3 High Cost Associated with the Treatment    

                                3.2.4 Low Success Rate in Clinical Trials for Cancer Drugs   

                3.3 Market Opportunities                          

                3.4 Market Threats                         

4. Porter’s Five Force Analysis                                    

                4.1 Bargaining Power of Suppliers                            

                4.2 Bargaining Power of Buyers                

                4.3 Degree of Competition                          

                4.4 Threat of Substitution                            

                4.5 Threat of New Entrants                         

5. Market Segmentation                                              

                5.1 North America Pancreatic Cancer Therapeutics & Diagnostic Market, by Cancer Type                               

                                5.1.1 Exocrine Cancers   

                                                5.1.1.1 Pancreatic Adenocarcinoma

                                                5.1.1.2 Acinar Cell Carcinoma

                                                5.1.1.3 Cystadenocarcinomas

                                                5.1.1.4 Others

                                5.1.2 Endocrine Cancers (PanNETs)         

                                                5.1.2.1 Functional

                                                5.1.2.2 Non-Functional

                5.2 North America Pancreatic Cancer Therapeutics Market                          

                                5.2.1 Surgery     

                                5.2.3 Radiation Therapy

                                5.2.3 Chemotherapy      

                                5.2.4 Chemoradiation Therapy   

                                5.2.5 Targeted Therapy 

                5.3 North America Pancreatic Cancer Diagnostics Market                              

                                5.3.1 ERCP          

                                5.3.2 Confirmatory Needle biopsy           

                                5.3.3 Endoscopic Ultrasound      

                                5.3.4 Laparoscopy           

                                5.3.5 CT Scan     

                                5.3.6 PET Scan   

                5.4 North America Pancreatic Cancer Therapeutics Market, By Region                    

                                5.4.1 U.S             

                                5.4.2 Canada     

                                5.4.3 Mexico     

6. Competitive Landscape                                           

                6.1 Mergers & Acquisitions                         

                6.2 Agreements, Collaborations & Partnerships                

                6.3 New Product Launches                         

                6.4 Recommendations to New Market Players                   

7. Company Profiles                                       

                7.1 Amgen, Inc.                 

                7.2 Eli Lilly and Company                              

                7.3 Celgene Corporation                              

                7.4 Clovis Oncology, Inc.                

                7.5 Novartis AG                

                7.6 Threshold Pharmaceuticals, Inc.                         

                7.7 Incyte Corp                 

                7.8 Merrimack Pharmaceuticals Inc.                         

                7.9 Roche Ltd                    

                7.10 NewLink Genetics                 

8. Appendix                                       

                8.1. Abbreviations                          

                8.2. Sources                       

                8.3. Bibliography                              

                8.4. Disclaimer                   

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?

Email

Message

By submitting, you confirm that you agree to our privacy policy